Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13

Showing 13 citing articles:

Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies
Timo Ulrichs, Morgane Rolland, Jian Wu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 510-522
Open Access | Times Cited: 4
Genomic Surveillance for SARS-CoV-2 Variants: Dominance of XBB Replacement — China, January–June 2023
Yenan Feng, Qiudong Su, Lili Li, et al.
Deleted Journal (2024) Vol. 6, Iss. 15, pp. 324-331
Open Access | Times Cited: 2
Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent
Yuanyuan Hu, Caiqin Hu, Shuo Wang, et al.
Pathogens (2024) Vol. 13, Iss. 4, pp. 272-272
Open Access
The Effective Inhibitory Concentration of Interferon-β Correlates with Infectivity and Replication Fitness of SARS-CoV-2 Variants
Janmejay Singh, Anbalagan Anantharaj, Parveen Kumar, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 7, pp. 325-333
Closed Access
Current Progress in Genomic and Genetic Research on Human Viral Diseases
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike
Liaoxin Fang, Xiaofeng Kang, Hong Qian, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29716-29727
Closed Access
A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
Qianyun Liu, Yuchi Lu, Chenguang Cai, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access
Editor response for version 1
Rubén de Dios
(2024)
Open Access
SciScore Report for version 1

(2023)
Open Access
Molecular evolution and adaptation of SARS-CoV-2 omicron XBB sub-lineage Spike protein under African Selection pressure.
Milton S Kambarami, Godwins Ngorima, Praise Moyo, et al.
(2023)
Open Access
iThenticate Report for version 1

(2023)
Open Access
COVID‐19 and cancer: Dichotomy of the menacing dilemma
Mrinal K. Ghosh, Shaheda Tabassum, Malini Basu
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access
Impact of mutations on Omicron's spike protein: Insights from variants found in Vietnam
Quan Ke Thai, H. Nguyen Phuoc
Vietnam Journal of Biotechnology (2023) Vol. 21, Iss. 4, pp. 621-635
Open Access
Page 1

Scroll to top